NO974270L - Insulinderivater - Google Patents
InsulinderivaterInfo
- Publication number
- NO974270L NO974270L NO974270A NO974270A NO974270L NO 974270 L NO974270 L NO 974270L NO 974270 A NO974270 A NO 974270A NO 974270 A NO974270 A NO 974270A NO 974270 L NO974270 L NO 974270L
- Authority
- NO
- Norway
- Prior art keywords
- insulin derivatives
- group
- chain
- amino acid
- terminal amino
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical class N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 2
- 125000001433 C-terminal amino-acid group Chemical group 0.000 abstract 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 230000005923 long-lasting effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK27695 | 1995-03-17 | ||
PCT/DK1996/000107 WO1996029344A1 (en) | 1995-03-17 | 1996-03-18 | Insulin derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
NO974270D0 NO974270D0 (no) | 1997-09-16 |
NO974270L true NO974270L (no) | 1997-11-14 |
Family
ID=8091725
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO974270A NO974270L (no) | 1995-03-17 | 1997-09-16 | Insulinderivater |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0871665B1 (cs) |
JP (1) | JP3872105B2 (cs) |
KR (1) | KR19980703039A (cs) |
CN (1) | CN1196061A (cs) |
AT (1) | ATE245659T1 (cs) |
AU (1) | AU720966B2 (cs) |
BR (1) | BR9607647A (cs) |
CA (1) | CA2215694A1 (cs) |
CZ (1) | CZ289343B6 (cs) |
DE (1) | DE69629210T2 (cs) |
HU (1) | HUP9800523A3 (cs) |
NO (1) | NO974270L (cs) |
PL (1) | PL183698B1 (cs) |
WO (1) | WO1996029344A1 (cs) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5693609A (en) * | 1994-11-17 | 1997-12-02 | Eli Lilly And Company | Acylated insulin analogs |
US6451970B1 (en) | 1996-02-21 | 2002-09-17 | Novo Nordisk A/S | Peptide derivatives |
US6268343B1 (en) | 1996-08-30 | 2001-07-31 | Novo Nordisk A/S | Derivatives of GLP-1 analogs |
US7235627B2 (en) | 1996-08-30 | 2007-06-26 | Novo Nordisk A/S | Derivatives of GLP-1 analogs |
US6458924B2 (en) | 1996-08-30 | 2002-10-01 | Novo Nordisk A/S | Derivatives of GLP-1 analogs |
WO1999021578A1 (en) * | 1997-10-24 | 1999-05-06 | Eli Lilly And Company | Insoluble insulin compositions |
US6531448B1 (en) | 1997-12-23 | 2003-03-11 | Eli Lilly And Company | Insoluble compositions for controlling blood glucose |
JP2002534959A (ja) * | 1998-12-08 | 2002-10-22 | バイオベーション リミテッド | 免疫原性タンパク質の改変方法 |
TWI242000B (en) * | 1998-12-10 | 2005-10-21 | Univ Southern California | Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use |
AU2003236201A1 (en) | 2002-05-07 | 2003-11-11 | Novo Nordisk A/S | Soluble formulations comprising monomeric insulin and acylated insulin |
CN1247616C (zh) * | 2002-07-19 | 2006-03-29 | 上海中科生龙达生物技术(集团)有限公司 | 新的单体胰岛素,药物组合物及其制法 |
BRPI0413276B8 (pt) | 2003-08-05 | 2021-05-25 | Novo Nordisk As | derivado de insulina, complexo de zinco do mesmo, e, composição farmacêutica |
JP2007532096A (ja) | 2003-11-14 | 2007-11-15 | ノボ ノルディスク アクティーゼルスカブ | アシル化されたインスリンの製造方法 |
ES2397241T3 (es) | 2004-01-21 | 2013-03-05 | Novo Nordisk Health Care Ag | Conjugación de péptidos mediante transglutaminasa |
MXPA06010347A (es) | 2004-03-17 | 2007-06-19 | 7Tm Pharma As | Agonistas de receptor selectivo de y2 para intervenciones terapeuticas. |
MXPA06010345A (es) | 2004-03-17 | 2007-06-19 | 7Tm Pharma As | Agonistas de receptor selectivo de y4 para intervenciones terapeuticas. |
EP1846446B1 (en) | 2005-02-02 | 2013-06-26 | Novo Nordisk A/S | Insulin derivatives |
ES2490243T3 (es) | 2005-02-02 | 2014-09-03 | Novo Nordisk A/S | Derivados de insulina |
PL1969004T3 (pl) | 2005-12-28 | 2012-01-31 | Novo Nordisk As | Kompozycje zawierające acylowaną insulinę i cynk oraz sposób wytwarzania tych kompozycji |
DE602007009496D1 (de) | 2006-02-27 | 2010-11-11 | Novo Nordisk As | Insulinderivate |
MX2008014061A (es) * | 2006-05-09 | 2008-11-14 | Novo Nordisk As | Derivado de insulina. |
CN101573133B (zh) | 2006-07-31 | 2014-08-27 | 诺沃-诺迪斯克有限公司 | Peg化延长的胰岛素 |
WO2008034881A1 (en) | 2006-09-22 | 2008-03-27 | Novo Nordisk A/S | Protease resistant insulin analogues |
JP5496082B2 (ja) | 2007-04-30 | 2014-05-21 | ノボ・ノルデイスク・エー/エス | タンパク質組成物を乾燥させる方法、乾燥タンパク質組成物、及び乾燥タンパク質を含有する薬学的組成物 |
WO2008152106A1 (en) | 2007-06-13 | 2008-12-18 | Novo Nordisk A/S | Pharmaceutical formulation comprising an insulin derivative |
US8710000B2 (en) | 2007-11-08 | 2014-04-29 | Novo Nordisk A/S | Insulin derivative |
EP2058330A1 (en) * | 2007-11-08 | 2009-05-13 | Novo Nordisk A/S | Insulin derivative |
EP2254905B1 (en) * | 2008-03-14 | 2016-12-14 | Novo Nordisk A/S | Protease-stabilized insulin analogues |
WO2009115469A1 (en) | 2008-03-18 | 2009-09-24 | Novo Nordisk A/S | Protease stabilized, acylated insulin analogues |
US9603904B2 (en) | 2008-10-30 | 2017-03-28 | Novo Nordisk A/S | Treating diabetes melitus using insulin injections with less than daily injection frequency |
BR112013010345A2 (pt) | 2010-10-27 | 2017-07-25 | Novo Nordisk As | tratamento de diabetes melitus usando as injeções de insulina administradas com intervalos de variação da injeção |
WO2013153000A2 (en) | 2012-04-11 | 2013-10-17 | Novo Nordisk A/S | Insulin formulations |
WO2014177623A1 (en) | 2013-04-30 | 2014-11-06 | Novo Nordisk A/S | Novel administration regime |
US9896496B2 (en) | 2013-10-07 | 2018-02-20 | Novo Nordisk A/S | Derivative of an insulin analogue |
AR099569A1 (es) | 2014-02-28 | 2016-08-03 | Novo Nordisk As | Derivados de insulina y los usos médicos de estos |
AU2017378102B2 (en) | 2016-12-16 | 2022-10-13 | Novo Nordisk A/S | Insulin containing pharmaceutical compositions |
TWI762706B (zh) | 2017-08-24 | 2022-05-01 | 丹麥商諾佛 儂迪克股份有限公司 | Glp-1組成物及其用途 |
US10335464B1 (en) | 2018-06-26 | 2019-07-02 | Novo Nordisk A/S | Device for titrating basal insulin |
AU2019398658A1 (en) | 2018-12-11 | 2021-07-29 | Sanofi | Insulin conjugates |
IL294520A (en) | 2020-02-18 | 2022-09-01 | Novo Nordisk As | Pharmaceutical formulations |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3844211A1 (de) * | 1988-12-29 | 1990-07-05 | Hoechst Ag | Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung |
DK155690D0 (da) * | 1990-06-28 | 1990-06-28 | Novo Nordisk As | Nye peptider |
RU2164520C2 (ru) * | 1993-09-17 | 2001-03-27 | Ново Нордиск А/С | Производное инсулина, растворимая пролонгированная фармацевтическая композиция, способ пролонгирования гипогликемического действия при лечении диабета |
-
1996
- 1996-03-18 KR KR1019970706447A patent/KR19980703039A/ko not_active Application Discontinuation
- 1996-03-18 WO PCT/DK1996/000107 patent/WO1996029344A1/en not_active Application Discontinuation
- 1996-03-18 JP JP52799596A patent/JP3872105B2/ja not_active Expired - Fee Related
- 1996-03-18 BR BR9607647A patent/BR9607647A/pt not_active Application Discontinuation
- 1996-03-18 DE DE69629210T patent/DE69629210T2/de not_active Expired - Lifetime
- 1996-03-18 PL PL96322299A patent/PL183698B1/pl unknown
- 1996-03-18 CZ CZ19972899A patent/CZ289343B6/cs not_active IP Right Cessation
- 1996-03-18 AU AU49396/96A patent/AU720966B2/en not_active Ceased
- 1996-03-18 CN CN96193362A patent/CN1196061A/zh active Pending
- 1996-03-18 CA CA002215694A patent/CA2215694A1/en not_active Abandoned
- 1996-03-18 EP EP96905764A patent/EP0871665B1/en not_active Expired - Lifetime
- 1996-03-18 AT AT96905764T patent/ATE245659T1/de not_active IP Right Cessation
- 1996-03-18 HU HU9800523A patent/HUP9800523A3/hu unknown
-
1997
- 1997-09-16 NO NO974270A patent/NO974270L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1196061A (zh) | 1998-10-14 |
CZ289997A3 (cs) | 1998-01-14 |
PL322299A1 (en) | 1998-01-19 |
MX9707056A (es) | 1997-11-29 |
AU4939696A (en) | 1996-10-08 |
DE69629210D1 (de) | 2003-08-28 |
DE69629210T2 (de) | 2004-04-22 |
JP3872105B2 (ja) | 2007-01-24 |
CA2215694A1 (en) | 1996-09-26 |
AU720966B2 (en) | 2000-06-22 |
HUP9800523A3 (en) | 1998-09-28 |
HUP9800523A2 (hu) | 1998-06-29 |
KR19980703039A (ko) | 1998-09-05 |
WO1996029344A1 (en) | 1996-09-26 |
BR9607647A (pt) | 1999-04-06 |
ATE245659T1 (de) | 2003-08-15 |
EP0871665A1 (en) | 1998-10-21 |
NO974270D0 (no) | 1997-09-16 |
PL183698B1 (pl) | 2002-06-28 |
CZ289343B6 (cs) | 2002-01-16 |
JPH11502110A (ja) | 1999-02-23 |
EP0871665B1 (en) | 2003-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO974270L (no) | Insulinderivater | |
NO974269L (no) | Lipofile peptidhormonderivater | |
NO20061026L (no) | Nye insulinderivater | |
ATE399177T1 (de) | Derivate therapeutischer peptide | |
ATE262037T1 (de) | Modifizierte liganden für den tie-2-rezeptor | |
HUP0100928A2 (hu) | Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
NO974514L (no) | Syntetisk HPV6/11 hybrid L1 DNA som koder for humant papillomavirus Type 11 L1-protein | |
HUP0003314A2 (hu) | GLP-1 analógok és származékok alkalmazása elhízás szabályozására használható gyógyszerkészítmények előállítására | |
AU9315398A (en) | Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response | |
ES2102052T3 (es) | Preparaciones medicas que contienen undecapeptidos ciclicos n-metilados. | |
ATE245435T1 (de) | Totalsynthese des amino hip analogen von didemnin a | |
ES2038675T3 (es) | Un procedimiento para preparar compuestos peptidicos. | |
KR850001775A (ko) | 인슐린 유도체의 제조방법 | |
DE69834929D1 (de) | Verwendung eines organspezifischen ernährungmittels | |
ATE195147T1 (de) | Aminosäuren konjugaten | |
MX9206732A (es) | Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas de tierra. | |
IT1277391B1 (it) | Peptidi ciclici analoghi della somatostatina ad attivita' inibitrice dell'ormone della crescita | |
WO1998050423A3 (fr) | Analogues peptidiques et leurs utilisations notamment dans des compositions pharmaceutiques et pour le diagnostic | |
SI1401871T1 (cs) | ||
MX9802268A (es) | Nuevos derivados de la substancia pf1022 de ciclodepsipeptido. | |
GT199300023A (es) | Derivados de aminoacidos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |